Publicaciones en las que colabora con Alfonso Leal Cerro (28)

2016

  1. El Registro Molecular de Adenomas Hipofisarios (REMAH): una apuesta de futuro de la Endocrinología española por la medicina individualizada y la investigación traslacional

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 63, Núm. 6, pp. 274-284

2005

  1. Erratum: Hypopituitarism following traumatic brain injury (TBI): A guideline Decalogue (Journal of Endocrinological Investigation (2004) 27, 8 (793))

    Journal of Endocrinological Investigation

  2. Prevalence of hypopituitarism and growth hormone deficiency in adults long-term after severe traumatic brain injury

    Clinical Endocrinology, Vol. 62, Núm. 5, pp. 525-532

2004

  1. Hypopituitarism following traumatic brain injury (TBI): A guideline decalogue

    Journal of Endocrinological Investigation, Vol. 27, Núm. 8, pp. 793-795

2003

  1. Effect of acute reduction of free fatty acids by acipimox on growth hormone-releasing hormone-induced GH secretion in type 1 diabetic patients

    Clinical Endocrinology, Vol. 59, Núm. 4, pp. 431-436

  2. Mechanisms underlying the neuroendocrine response to physical exercise

    Journal of Endocrinological Investigation, Vol. 26, Núm. 9, pp. 879-885

  3. Protocolo unificado de utilización de la hormona del crecimiento en pacientes adultos deficitarios

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 50, Núm. 2, pp. 49-51

2002

  1. Diagnóstico del déficit de hormona del crecimiento en pacientes adultos

    Endocrinologia y Nutricion

  2. Diagnóstico del déficit de hormona del crecimiento en pacientes adultos

    Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología y Nutrición, Vol. 49, Núm. 10, pp. 313-315

  3. Effect of withdrawal of somatostatin plus GH-releasing hormone as a stimulus of GH secretion in obesity

    Clinical Endocrinology, Vol. 56, Núm. 4, pp. 487-492

  4. Effect of withdrawal of somatostatin plus growth hormone (GH)-releasing hormone as a stimulus of GH secretion in Cushing's syndrome

    Clinical Endocrinology, Vol. 57, Núm. 6, pp. 745-749

  5. Ghrelin is no longer able to stimulate growth hormone secretion in patients with Cushing's syndrome but instead induces exaggerated corticotropin and cortisol responses

    Neuroendocrinology, Vol. 76, Núm. 6, pp. 390-396

2001

  1. Influence of cortisol status on leptin secretion

    Pituitary, Vol. 4, Núm. 1-2, pp. 111-116

  2. Physiology and possible pathology of growth hormone secretagogues

    Journal of Pediatric Endocrinology and Metabolism, Vol. 14, Núm. SUPPL. 5, pp. 1207-1212

1999

  1. The growth hormone (GH)-releasing hormone - GH - insulin-like growth factor-1 axis in patients with fibromyalgia syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 84, Núm. 9, pp. 3378-3381

1998

  1. Enhanced growth hormone (GH) responsiveness to GH-releasing hormone after dietary restriction in patients with Cushing's syndrome

    Clinical Endocrinology, Vol. 48, Núm. 1, pp. 117-121

  2. Serum leptin levels in male marathon athletes before and after the marathon run

    Journal of Clinical Endocrinology and Metabolism, Vol. 83, Núm. 7, pp. 2376-2379

  3. Theoretical considerations in estimating the growth hormone axis in adults

    Growth Hormone and IGF Research, Vol. 8, Núm. SUPPL. 2, pp. 93-96

1997

  1. Acute pharmacological reduction of plasma free fatty acids enhances the growth hormone (GH)-releasing hormone-mediated GH secretion in patients with Cushing's syndrome

    Journal of Clinical Endocrinology and Metabolism, Vol. 82, Núm. 9, pp. 3165-3168

  2. Neuropharmacological assessment of growth hormone secretion

    Acta Paediatrica, International Journal of Paediatrics, Supplement